Know Cancer

or
forgot password

Application of CO2 Insufflations in Colonoscopy Examination-A Single-blinded Randomized Trial


N/A
18 Years
80 Years
Open (Enrolling)
Both
Colorectal Neoplasm, Colorectal Cancer

Thank you

Trial Information

Application of CO2 Insufflations in Colonoscopy Examination-A Single-blinded Randomized Trial


- Setting: Screening colonoscopy or secondary colonoscopy after positive FOBT performed
in endoscopic unit of a single university hospital

- Study design: Single blinded randomized trial

- Randomization process: sealed envelope

- Study subjects:

Inclusion criteria: Subjects who receive Screening colonoscopy or secondary colonoscopy
Exclusion criteria: subjects who have COPD or cardiovascular diseases

- Study duration: June 2008 to November 2012

- Post-colonoscopy discomfort will be measured and obtained from the screenee at several
time points using visual analogue pain scoring system:

- Immediately after colonoscopy for non-sedated patients, immediately after awaken
from sedation for sedated patients

- 2 hrs after colonoscopy

- 8-12 hours after colonoscopy

- Statistical analysis:

- Sample size estimation: according to our previous unpublished data using air
insufflations at colonoscopy, mean pain score was 3 and standard deviation was
2.38. Assuming 15% difference of discomfort, sample size up to 171 are required
for each group (CO2 vs. air, sedated and non-sedated) in this study. (2 sided
test, α=0.05, power=80%)

- Student t-test for pain score comparison

- Ancillary analysis: pCO2, sedation drug dosage, and procedural time in both
groups. For TCCO2 comparison, ANOVA for repeated measurement will be used. For
variables not normally distributed, Wilcoxon rank sum test wall be used as a
supplementary analysis.

- SAS statistical program, version 9.0 (SAS institute Inc., Cary, NC) will be used
for all statistical analysis


Inclusion Criteria:



- Subjects who receive Screening colonoscopy or secondary colonoscopy

Exclusion Criteria:

- Subjects who have COPD or cardiovascular diseases

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Screening

Outcome Measure:

Degree of abdominal discomfort during and after colonoscopy

Outcome Time Frame:

0, 2, 8-10 hr

Safety Issue:

Yes

Principal Investigator

Hsiu-Po Wang, MD

Investigator Role:

Study Director

Investigator Affiliation:

National Taiwan University Hospital

Authority:

Taiwan: Department of Health

Study ID:

200802031R

NCT ID:

NCT00745927

Start Date:

June 2008

Completion Date:

August 2012

Related Keywords:

  • Colorectal Neoplasm
  • Colorectal Cancer
  • Colorectal neoplasm
  • Colorectal cancer
  • Screening colonoscopy
  • CO2 insufflations
  • Colonoscopy
  • Neoplasms
  • Colorectal Neoplasms

Name

Location